Articles tagged with “chai-3-model”

Chai Discovery Series C Valuation Hits $3.8B in 2026

A 2026 analyst report on Chai Discovery's $400M Series C at a $3.8B valuation, covering Chai-3 benchmarks, Lilly, Pfizer, Novartis, and argenx deals, and AI drug discovery megaround trends.

35 min read

7/20/2026

chai discovery series c valuation ai drug discovery chai-3 model isomorphic labs index ventures antibody design ai venture funding 2026

Generative Antibody Design: Chai-3 and Pharma AI Strategy

Learn how generative antibody design models like Chai-3 operate, and analyze Pfizer's licensing strategy and the pharma AI build-versus-partner decision.

30 min read

6/13/2026

generative antibody design chai-3 model ai drug discovery zero-shot design pfizer ai strategy pharma ai playbook de novo protein design biotechnology